Prospective validation of the modified metastatic colorectal cancer score (mCCS) in >600 patients with RAS-wild-type metastatic colorectal cancer treated with first-line panitumumab plus FOLFIRI/FOLFOX: Final results of the non-interventional study VALIDATE
一项前瞻性研究对超过 600 例接受一线帕尼单抗联合 FOLFIRI/FOLFOX 方案治疗的 RAS 野生型转移性结直肠癌患者进行了改良转移性结直肠癌评分 (mCCS) 的验证：非干预性研究 VALIDATE 的最终结果
期刊:International Journal of Cancer
影响因子:4.7
doi:10.1002/ijc.70139
Potthoff, Karin; Uhlig, Jens; Jacobasch, Lutz; Müller, Lothar; Reiser, Marcel; de Buhr, Rebecca; Polata, Silke; Gerger, Armin; Zehrer, Viktor; Amann, Arno; Göhler, Thomas; Serrer, Laura; Schröder, Jan; Semsek, Dieter; Köhler, Andreas; Stübs, Patrick; Prager, Gerald; Siebenbach, Hans Ulrich; Schuch, Anita; Marschner, Norbert
